Paige, PathAI, Ibex, Proscia and Aiforia occupy the clinical pathology AI top-tier; big-tech entrants (e.g., Google DeepMind) loom in research alliances.
P
PathAI
Recently secured 510(k) for AISight viewer variant (Jun 2025)
I
Ibex
Matched prostate clearance (Feb 2025)
P
Proscia
Strong in computational pathology solutions
A
Aiforia
Specializes in AI-assisted image analysis
Key Insight
Paige still leads on FDA clearances, but competitors are rapidly closing the regulatory gap, with Ibex and PathAI making significant progress in 2025.